causal
Consumers Will Accept Compounded Risk at Lower Price
Patients who cannot afford $400 to $500 a month will still take compounded GLP-1s that have had no clinical trials, because they value the benefit enough to accept unknown manufacturing and safety risks at about $200 to $250 a month.
causalpending
Speaker
Alex KarnalEvidence Quote
“they could afford $200, $250 a month.”
Source
Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]— Invest Like the BestCreated: 11/14/2026, 4:24:39 AM
Your notes
Loading notes...